Two Sigma Investments
WX

Two Sigma Investments’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Two Sigma Investments’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-47,700
Closed -$2.06M – 3191
2015
Q3 		$2.06M Sell
47,700
-204,225
-81% -$8.62M 0.01% 834
2015
Q2 		$10.6M Buy
251,925
+224,425
+816% +$9.46M 0.05% 432
2015
Q1 		$1.07M Sell
27,500
-114,153
-81% -$4.4M 0.01% 1538
2014
Q4 		$4.77M Sell
141,653
-137,738
-49% -$4.86M 0.03% 661
2014
Q3 		$9.78M Buy
279,391
+63,706
+30% +$2.18M 0.04% 447
2014
Q2 		$7.09M Buy
+215,685
New +$7.38M 0.03% 600
2014
Q1 		– Sell
-84,100
Closed -$3.23M – 2491
2013
Q4 		$3.23M Sell
84,100
-51,632
-38% -$1.63M 0.02% 791
2013
Q3 		$3.72M Sell
135,732
-130,413
-49% -$3.09M 0.02% 598
2013
Q2 		$5.59M Buy
+266,145
New +$5.2M 0.04% 501

Other funds holding WX

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Two Sigma Investments's WX Position: Q4 2015 in Review

Two Sigma Investments sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 47,700 shares — an estimated $2.06M sold.

Two Sigma Investments first reported a position in WX in Q2 2013 and held it in 9 quarters. The position peaked at $10.6M in Q2 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • Two Sigma Investments reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • Two Sigma Investments sold 47,700 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $2.06M.
  • Two Sigma Investments first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 9 quarters.
  • Two Sigma Investments's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $10.6M in Q2 2015.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Two Sigma Investments's 13F filing for Q4 2015, filed 16 Feb 2016.